Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Double-blind, Dose-finding, Placebo-controlled Study to Assess the Safety and Efficacy of a Single Oral Administration of OBE001 to Improve Embryo Implantation Following IVF or ICSI

NCT02310802 is registered in ClinicalTrials.gov with ObsEva SA as lead sponsor.

NCT NCT02310802
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02310802 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Double-blind, Dose-finding, Placebo-controlled Study to Assess the Safety and Efficacy of a Single Oral Administration of OBE001 to Improve Embryo Implantation Following IVF or ICSI
Lead sponsor
ObsEva SA
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2014
Completion date
December 31, 2016
Enrollment
247 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

infertility